CFA
Cahill Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $202K | Hold |
1,600
| – | – | 0.03% | 269 |
|
2025
Q1 | $205K | Buy |
1,600
+1
| +0.1% | +$128 | 0.03% | 260 |
|
2024
Q4 | $211K | Sell |
1,599
-21
| -1% | -$2.78K | 0.03% | 250 |
|
2024
Q3 | $236K | Sell |
1,620
-229
| -12% | -$33.3K | 0.03% | 232 |
|
2024
Q2 | $254K | Hold |
1,849
| – | – | 0.03% | 237 |
|
2024
Q1 | $254K | Sell |
1,849
-991
| -35% | -$136K | 0.03% | 234 |
|
2023
Q4 | $386K | Sell |
2,840
-610
| -18% | -$82.9K | 0.06% | 181 |
|
2023
Q3 | $422K | Buy |
3,450
+8
| +0.2% | +$978 | 0.07% | 169 |
|
2023
Q2 | $437K | Buy |
3,442
+759
| +28% | +$96.4K | 0.07% | 173 |
|
2023
Q1 | $346K | Sell |
2,683
-1,267
| -32% | -$164K | 0.06% | 178 |
|
2022
Q4 | $519K | Buy |
3,950
+1,322
| +50% | +$174K | 0.1% | 147 |
|
2022
Q3 | $307K | Buy |
+2,628
| New | +$307K | 0.06% | 180 |
|
2018
Q4 | – | Sell |
-2,926
| Closed | -$357K | – | 149 |
|
2018
Q3 | $357K | Buy |
2,926
+1,000
| +52% | +$122K | 0.16% | 123 |
|
2018
Q2 | $212K | Buy |
+1,926
| New | +$212K | 0.1% | 147 |
|
2017
Q4 | – | Sell |
-716
| Closed | -$239K | – | 141 |
|
2017
Q3 | $239K | Buy |
+716
| New | +$239K | 0.13% | 123 |
|